Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Small Molecule Drug Discovery Market, by region, 2019-2027 (USD Billion)
1.2.2. Small Molecule Drug Discovery Market, by Therapeutic Area, 2019-2027 (USD Billion)
1.2.3. Small Molecule Drug Discovery Market, by Process/Phase, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Small Molecule Drug Discovery Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Small Molecule Drug Discovery Market Dynamics
3.1. Small Molecule Drug Discovery Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Increasing Number of Contract Organizations for R&D
3.1.1.2. Rise in Demand for Small Molecule Drugs
3.1.2. Market Restraint
3.1.2.1. High Drug Development Costs
3.1.2.2. Strict Regulations
3.1.3. Market Opportunities
3.1.3.1. Rising technological advancements
Chapter 4. Global Small Molecule Drug Discovery Market: Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Small Molecule Drug Discovery Market, by Therapeutic Area
5.1. Market Snapshot
5.2. Global Small Molecule Drug Discovery Market by Therapeutic Area, Performance - Potential Analysis
5.3. Global Small Molecule Drug Discovery Market Estimates & Forecasts by Therapeutic Area 2018-2027 (USD Billion)
5.4. Small Molecule Drug Discovery Market, Sub Segment Analysis
5.4.1. Oncology
5.4.2. Central Nervous System
5.4.3. Cardiovascular
5.4.4. Respiratory
5.4.5. Metabolic Disorders
5.4.6. Gastrointestinal
5.4.7. Other Therapeutic Areas
Chapter 6. Global Small Molecule Drug Discovery Market, by Process/Phase
6.1. Market Snapshot
6.2. Global Small Molecule Drug Discovery Market by Process/Phase, Performance - Potential Analysis
6.3. Global Small Molecule Drug Discovery Market Estimates & Forecasts by Process/Phase 2018-2027 (USD Billion)
6.4. Small Molecule Drug Discovery Market, Sub Segment Analysis
6.4.1. Target ID/Validation
6.4.2. Hit Generation and Selection
6.4.3. Lead Identification
6.4.4. Lead Optimization
Chapter 7. Global Small Molecule Drug Discovery Market, Regional Analysis
7.1. Small Molecule Drug Discovery Market, Regional Market Snapshot
7.2. North America Small Molecule Drug Discovery Market
7.2.1. U.S. Small Molecule Drug Discovery Market
7.2.1.1. Therapeutic Area breakdown estimates & forecasts, 2018-2027
7.2.1.2. Process/Phase breakdown estimates & forecasts, 2018-2027
7.2.2. Canada Small Molecule Drug Discovery Market
7.3. Europe Small Molecule Drug Discovery Market Snapshot
7.3.1. U.K. Small Molecule Drug Discovery Market
7.3.2. Germany Small Molecule Drug Discovery Market
7.3.3. France Small Molecule Drug Discovery Market
7.3.4. Spain Small Molecule Drug Discovery Market
7.3.5. Italy Small Molecule Drug Discovery Market
7.3.6. Rest of Europe Small Molecule Drug Discovery Market
7.4. Asia-Pacific Small Molecule Drug Discovery Market Snapshot
7.4.1. China Small Molecule Drug Discovery Market
7.4.2. India Small Molecule Drug Discovery Market
7.4.3. Japan Small Molecule Drug Discovery Market
7.4.4. Australia Small Molecule Drug Discovery Market
7.4.5. South Korea Small Molecule Drug Discovery Market
7.4.6. Rest of Asia Pacific Small Molecule Drug Discovery Market
7.5. Latin America Small Molecule Drug Discovery Market Snapshot
7.5.1. Brazil Small Molecule Drug Discovery Market
7.5.2. Mexico Small Molecule Drug Discovery Market
7.6. Rest of The World Small Molecule Drug Discovery Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Boehringer Ingelheim GmbH
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. 21st Century Therapeutics Inc.
8.2.3. Agilent Technologies Inc.
8.2.4. Bristol-Myers Squibb Company
8.2.5. Acacia Pharma Gr
8.2.6. GlaxoSmithKline PLC
8.2.7. Gilead Sciences Inc.
8.2.8. Johnson & Johnson
8.2.9. AstraZeneca
8.2.10. 4SC-Discovery
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption